H. Zimermam

Reproducibility of a 12-gene set for predicting outcome and benefit from ACT in early-stage NSCLC patients

A. Fabro, C. Souto-Moura, S. Batah, 2023, Lung cancer.

Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients

A. Fabro, C. Souto-Moura, S. Batah, 2023, Lung cancer.